Key facts
as of Sep 2026- Odyssey Therapeutics’s last known valuation is $638.2M (Aug 2024).
- It has raised $716.2M across 4 recorded rounds; the latest was Later Stage VC ($214.0M) in Jun 2025.
- Notable investors include General Catalyst, Fidelity Management & Research Company, KB Investment, Alexandria Venture Investments, OrbiMed — 32 tracked in total.
- 1 institutional filer reports fund marks on Odyssey Therapeutics across 1 filings.
- Odyssey Therapeutics has filed 5 Form Ds with the SEC since 2021, most recently Dec 2025 ($214.0M sold to 55 investors).
- Status: In IPO Registration.
PA Mark — composite indicative price
LOW confidence~$17per share
as of Sep 2026 · the exact daily mark is a member feature
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 32 names
- ·Watchlist + deal alerts for Odyssey Therapeutics
Create free account
No card required
Recorded secondary trades
No prints on record
No secondary trades in Odyssey Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
1 filers · latest May 20261 SEC-registered fund reported 1 fair-value mark on Odyssey Therapeutics between May 2026 and May 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
4 roundsOct 2022Early Stage VC (Series B)$168.0M▮
About Odyssey Therapeutics
Operator of a biotechnology company intended to develop immunomodulators and oncology drugs. The company aims to advance the drug discovery space with its product pipeline and accelerate the path of clinical development, enabling the healthcare industry to get next-generation precision immunomodulators and oncology medicines.
- Industry
- Biotechnology
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2018
- Employees
- 118
- Website
- odysseytx.com/
- Ownership
- In IPO Registration